Assessment of triple antiphospholipid antibody-positive patients based on clinical and laboratory domains of 2023 ACR/EULAR antiphospholipid syndrome classification criteria

Autoimmune Disease

Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-C Report: Assessment of Patient Scenarios (Derivation Cohort) and Refinement of Definitions

Arthritis Care Res (Hoboken)

Barbhaiya M, Zuily S, Jannat-Khah D, Amigo MC, Andrade D, Avcin T, Bertolaccini ML, Branch DW, Costedoat-Chalumeau N, de Jesús GR, Devreese KMJ, Garcia D, Gomez Puerta JA, Guillemin F, Levine SR, Levy RA, Lockshin MD, Ortel TL, Petri M, Sanna G, Sciascia S, Seshan SV, Tektonidou M, Wahl D, Willis R, Yelnik C, Hendry A, Naden R, Costenbader KH, Erkan D, New APS Classification Criteria Collaborators

doi: 10.1002/acr.25599

Further Publications Immunology

Predictors of Mortality in Antiphospholipid Antibody Positive Patients: Prospective Results from Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository ("Registry")

Arthritis Care Res (Hoboken)

Ahmadzadeh Y, Magder LS, de Andrade DCO, Paredes-Ruiz D, Tektonidou MG, Pengo V, Sciascia S, Andreoli L, Signorelli F, Fortin PR, Efthymiou M, Belmont HM, Barilaro G, Clarke AE, Atsumi T, López-Pedrera C, Knight JS, Branch DW, Willis R, Kello N, Zhang Z, Rodriguez Almaraz E, Artim-Esen B, Pardos-Gea J, Pons-Estel G, Pazzola G, Shi H, Duarte-García A, Thaler J, Barber MRW, Skeith L, Radin M, Meroni PL, Roubey R, Bertolaccini ML, Cohen H, Petri M, Erkan D

doi: 10.1002/acr.25503

Psoriatic Arthritis

Association of achieving clinical disease control criteria and patient-reported outcomes in bimekizumab-treated patients with active psoriatic arthritis: results from two phase III studies

Ther Adv Musculoskelet Dis

Kristensen LE, Tillett W, Nash P, Coates LC, Mease PJ, Ogdie A, Gisondi P, Ink B, Prickett AR, Bajracharya R, Taieb V, Lyris N, Lambert J, Walsh JA

doi: 10.1177/1759720X241288071

Systemic Sclerosis

Phenotype of diffuse cutaneous systemic sclerosis patients with positive anticentromere antibodies: A systematic literature review and meta-analysis

Semin Arthritis Rheum

Binda M, Ortolan A, Moccaldi B, Salvato M, Cuberli A, Padoan R, Doria A, Zanatta E

doi: 10.1016/j.semarthrit.2024.152606

Rheumatoid Arthritis

EULAR/ACR risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgia

Ann Rheum Dis

van Steenbergen HW, Doornkamp F, Alivernini S, Backlund J, Codreanu C, Cohen SB, Combe B, Cope AP, Deane KD, England BR, Falahee M, de Jong PHP, Kleyer A, Lacaille D, Maat B, Mankia K, van Mulligen E, Nagy G, O'Neil LJ, Rodamaker L, Sahbudin I, van Schaardenburg D, Sepriano A, da Silva JAP, De Smet L, Sparks JA, Steyerberg EW, Studenic P, Wethington E, Landewé RL, Raza K, van der Helm-van Mil AHM

doi: 10.1016/j.ard.2025.01.021

Further Publications Rheumatology

The clinical assessment of lung involvement in patients with Still's disease, results from the multicentre international AIDA Network Still's Disease Registry

Rheumatology (Oxford)

Ruscitti P, Vitale A, Di Cola I, Caggiano V, Palumbo P, Di Cesare E, Hinojosa-Azaola A, Torres-Ruiz J, Guaracha-Basañez GA, Martín-Nares E, Lopalco G, Morrone M, Iannone F, Giardini HAM, Cordeiro RA, de Brito Antonelli IP, Berardicurti O, Navarini L, Ciccia F, Visconti MC, Iacono D, Direskeneli H, Erten S, Yao H, Thabet M, Tharwat S, Ragab G, Gómez-Caverzaschi V, Sfikakis PP, Fotis L, La Torre F, Maier A, Karamanakos A, Almaghlouth IA, Frassi M, Tufan A, Govoni M, Sota J, Simonini G, Emmi G, Li Gobbi F, Parronchi P, Costi S, Sarzi-Puttini P, Opris-Belinski D, Sfriso P, Tarsia M, Maggio MC, Monti S, Gündüz ÖS, Rigante D, Bartoloni E, Verrecchia E, Iagnocco A, Viapiana O, Bargagli E, Batu ED, Sebastiani GD, Del Giudice E, Conti G, Breda L, Gidaro A, Gicchino MF, Gaggiano C, Brucato AL, Triggianese P, Makowska J, Carubbi F, Farina N, Guggino G, De Paulis A, Mazzei MA, Di Meglio N, Lo Gullo A, Conforti A, Ogunjimi B, Calabrese L, Rubegni P, Giardina A, Wiesik-Szewczyk E, Balistreri A, Fabiani C, Frediani B, Dagna L, Giacomelli R, Cantarini L

doi: 10.1093/rheumatology/keaf021

Systemic Lupus Erythematosus

Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trial

Ann Rheum Dis

Branch DW, Kim MY, Guerra MM, Worden J, Laskin CA, DeSancho MT, Landres IV, Knight JS, Slosberg HS, Minett M, Salmon JE

doi: 10.1016/j.ard.2025.02.012

Further Publications Immunology

De-escalating Dual Antiplatelet Therapy to Ticagrelor Monotherapy in Acute Coronary Syndrome : A Systemic Review and Individual Patient Data Meta-Analysis of Randomized Clinical Trials

Ann Intern Med

Lee YJ, Gao X, Lee SH, Kan J, Zhang JJ, Lee SJ, Hong SJ, Ahn CM, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Stone GW, Chen SL, Hong MK

doi: 10.7326/ANNALS-24-03102

Atopic Dermatitis

The efficacy of longer-term lebrikizumab treatment in patients with moderate-to-severe atopic dermatitis who did not meet protocol-defined response criteria at week 16 in two randomized controlled clinical trials

J Am Acad Dermatol

Guttman-Yassky E, Rosmarin D, de Bruin-Weller M, Weidinger S, Bieber T, Hong HC, Elmaraghy H, Atwater AR, Pierce E, Xu C, Agell H, Gil EG, Simpson E

doi: 10.1016/j.jaad.2024.12.026

Related content